AAAAAA

   
Results: 1-12 |
Results: 12
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
Authors: Steele, JPC O'Doherty, CA Shamash, J Evans, MT Gower, NH Tischkowitz, MD Rudd, RM
Citation: Jpc. Steele et al., Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma, ANN ONCOL, 12(4), 2001, pp. 497-499
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study
Authors: Shamash, J McLaren, B LeVay, JH Ong, J Murray, P Asterling, S Oliver, RTD
Citation: J. Shamash et al., Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study, CANC CHEMOT, 47(4), 2001, pp. 370-372
Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?
Authors: Berney, DM Shamash, J Pieroni, K Oliver, RTD
Citation: Dm. Berney et al., Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?, HISTOPATHOL, 39(4), 2001, pp. 382-385
Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
Authors: Berney, DM Shamash, J Hendry, WF Arora, A Jordan, S Oliver, RT
Citation: Dm. Berney et al., Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?, BR J CANC, 84(3), 2001, pp. 340-343
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma
Authors: Shamash, J Walewski, J Apostolidis, J Wilson, AM Foran, JM Gupta, RK Rohatiner, AZS Kelsey, SM Lister, TA
Citation: J. Shamash et al., Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma, ANN ONCOL, 11(7), 2000, pp. 857-860
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
Authors: Shamash, J Lee, SM Radford, JA Rohatiner, AZS Chang, J Morgenstern, GR Scarffe, JH Deakin, DP Lister, TA
Citation: J. Shamash et al., Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study, ANN ONCOL, 11(6), 2000, pp. 715-719
Phase II study of vinorelbine in patients with malignant pleural mesothelioma
Authors: Steele, JPC Shamash, J Evans, MT Gower, NH Tischkowitz, MD Rudd, RM
Citation: Jpc. Steele et al., Phase II study of vinorelbine in patients with malignant pleural mesothelioma, J CL ONCOL, 18(23), 2000, pp. 3912-3917
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Authors: Shamash, J O'Doherty, CA Oliver, RTD Kelsey, S Gupta, RK Gallagher, CJ Newland, AC Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours - reply
Authors: Shamash, J
Citation: J. Shamash, Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours - reply, BR J CANC, 83(9), 2000, pp. 1258-1259
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
Authors: Shamash, J Oliver, RTD Gallagher, CJ Newland, AC Lister, TA Kelsey, S Gupta, RK O'Doherty, CA
Citation: J. Shamash et al., Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy, BR J CANC, 82(12), 2000, pp. 2022-2023
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy
Authors: Shamash, J Oliver, RTD Ong, J Raja, M Edmonds, P Gallagher, CJ Ostrowski, MJ LeVay, J Williams, M
Citation: J. Shamash et al., Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy, ANN ONCOL, 10(6), 1999, pp. 685-692
Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma
Authors: King, LJ Hasnain, SN Webb, JAW Kingston, JE Shafford, EA Lister, TA Shamash, J Reznek, RH
Citation: Lj. King et al., Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma, RADIOLOGY, 213(1), 1999, pp. 167-172
Risultati: 1-12 |